lansoprazole has been researched along with Autoimmune Thrombocytopenia in 17 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Helicobacter pylori-infected patients with gastritis and gastric ulcer received eradication therapy: lansoprazole (60 mg/day), clarithromycin (400 mg/day), and amoxicillin (1500 mg/day) for 1 week." | 3.74 | Helicobacter pylori eradication reduces platelet count in patients without idiopathic thrombocytopenic purpura. ( Arakawa, Y; Hatta, Y; Hayashi, I; Iwamoto, M; Kato, K; Kurihara, R; Kurosaka, H; Matsukawa, Y; Mizuno, S; Sawada, S, 2007) |
| "pylori infection and idiopathic thrombocytopenic purpura (ITP)." | 2.42 | [Evaluation of the efficacy of an Helicobacter pylori eradication treatment for idiopathic thrombocytopenic purpura patients]. ( Hirashima, N; Ito, K; Kato, A; Kato, H; Kondo, H; Matsunaga, S; Nukaya, H; Sakakibara, K; Sakamoto, T; Tanaka, Y, 2004) |
| "A 53-year-old woman had demonstrated idiopathic thrombocytopenic purpura (ITP) and iron deficiency anemia (IDA) since 1978." | 1.35 | Iron deficiency anemia successfully treated by Helicobacter pylori eradication in a patient with idiopathic thrombocytopenic purpura. ( ASAKA, M; HASHINO, S; IMAMURA, M; KAHATA, K; KONDO, T; MORITA, R; OKADA, K; ONOZAWA, M; TAKAHATA, M, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 14 (82.35) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, H | 1 |
| Lee, WS | 1 |
| Lee, KH | 1 |
| Bae, SH | 1 |
| Kim, MK | 1 |
| Joo, YD | 1 |
| Zang, DY | 1 |
| Jo, JC | 1 |
| Lee, SM | 1 |
| Lee, JH | 2 |
| Kim, DY | 1 |
| Ryoo, HM | 1 |
| Hyun, MS | 1 |
| Kim, HJ | 1 |
| Tsumoto, C | 1 |
| Tominaga, K | 1 |
| Okazaki, H | 1 |
| Tanigawa, T | 1 |
| Yamagami, H | 1 |
| Watanabe, K | 3 |
| Nakao, T | 1 |
| Koh, K | 1 |
| Watanabe, T | 1 |
| Fujiwara, Y | 1 |
| Yamane, T | 1 |
| Oshitani, N | 1 |
| Hino, M | 1 |
| Higuchi, K | 1 |
| Arakawa, T | 1 |
| MORITA, R | 1 |
| HASHINO, S | 1 |
| OKADA, K | 1 |
| TAKAHATA, M | 1 |
| ONOZAWA, M | 1 |
| KAHATA, K | 1 |
| KONDO, T | 1 |
| IMAMURA, M | 3 |
| ASAKA, M | 3 |
| Matsukawa, Y | 2 |
| Iwamoto, M | 2 |
| Kato, K | 2 |
| Mizuno, S | 2 |
| Gon, Y | 1 |
| Hemmi, A | 1 |
| Shirinskaya, N | 1 |
| Takeuchi, J | 1 |
| Sawada, S | 2 |
| Sato, R | 2 |
| Murakami, K | 2 |
| Okimoto, T | 2 |
| Kodama, M | 2 |
| Fujioka, T | 2 |
| Kohda, K | 1 |
| Kuga, T | 1 |
| Kogawa, K | 1 |
| Kanisawa, Y | 1 |
| Koike, K | 1 |
| Kuroiwa, G | 1 |
| Hirayama, Y | 1 |
| Sato, Y | 1 |
| Niitsu, Y | 1 |
| Asaumi, N | 2 |
| Masuda, K | 1 |
| Yoshida, C | 2 |
| Kiguchi, T | 1 |
| Niiya, M | 2 |
| Niiya, K | 2 |
| Tanimoto, M | 2 |
| Shibakura, M | 1 |
| Miyajima, H | 1 |
| Ogata, M | 1 |
| Ohtsuka, E | 1 |
| Saburi, Y | 1 |
| Nasu, M | 1 |
| Tsutsumi, Y | 2 |
| Kanamori, H | 2 |
| Yamato, H | 2 |
| Ehira, N | 2 |
| Miura, T | 1 |
| Kawamura, T | 2 |
| Obara, S | 2 |
| Tanaka, J | 2 |
| Masauzi, N | 2 |
| Kato, A | 1 |
| Kato, H | 1 |
| Hirashima, N | 1 |
| Sakamoto, T | 1 |
| Nukaya, H | 1 |
| Ito, K | 1 |
| Matsunaga, S | 1 |
| Kondo, H | 1 |
| Tanaka, Y | 1 |
| Sakakibara, K | 1 |
| Umehara, S | 1 |
| Mori, A | 1 |
| Ogura, N | 1 |
| Konno, M | 1 |
| Sayan, O | 1 |
| Akyol Erikci, A | 1 |
| Ozturk, A | 1 |
| Hatta, Y | 1 |
| Kurihara, R | 1 |
| Arakawa, Y | 1 |
| Kurosaka, H | 1 |
| Hayashi, I | 1 |
| Litton, G | 1 |
| Goto, H | 1 |
| Kikuta, T | 1 |
| Ota, A | 1 |
| Tsuji, H | 1 |
| Hino, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy of Helicobacter Pylori Eradication for the 1st Line Treatment of Immune Thrombocytopenic Purpura (ITP) Patients With Moderate Thrombocytopenia[NCT01255332] | 26 participants (Anticipated) | Observational | 2010-09-30 | Recruiting | |||
| Helicobacter Pylori and it's Hematological Impact[NCT03629587] | 100 participants (Actual) | Observational | 2016-09-27 | Completed | |||
| Efficacy of Helicobacter Pylori Eradication for the Treatment of Chronic or Persistent Immune Thrombocytopenic Purpura Patients With Moderate Thrombocytopenia: Multicenter Prospective Randomized Phase 3 Study[NCT03177629] | Phase 3 | 54 participants (Anticipated) | Interventional | 2017-05-23 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for lansoprazole and Autoimmune Thrombocytopenia
| Article | Year |
|---|---|
[Evaluation of the efficacy of an Helicobacter pylori eradication treatment for idiopathic thrombocytopenic purpura patients].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Infective Agents; Clarithromycin; D | 2004 |
[Helicobacter pylori eradication therapy for children].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents | 2005 |
4 trials available for lansoprazole and Autoimmune Thrombocytopenia
| Article | Year |
|---|---|
Efficacy of Helicobacter pylori eradication for the 1st line treatment of immune thrombocytopenia patients with moderate thrombocytopenia.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicoba | 2015 |
Efficacy of Helicobacter pylori eradication for the 1st line treatment of immune thrombocytopenia patients with moderate thrombocytopenia.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicoba | 2015 |
Efficacy of Helicobacter pylori eradication for the 1st line treatment of immune thrombocytopenia patients with moderate thrombocytopenia.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicoba | 2015 |
Efficacy of Helicobacter pylori eradication for the 1st line treatment of immune thrombocytopenia patients with moderate thrombocytopenia.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicoba | 2015 |
Efficacy of Helicobacter pylori eradication for the 1st line treatment of immune thrombocytopenia patients with moderate thrombocytopenia.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicoba | 2015 |
Efficacy of Helicobacter pylori eradication for the 1st line treatment of immune thrombocytopenia patients with moderate thrombocytopenia.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicoba | 2015 |
Efficacy of Helicobacter pylori eradication for the 1st line treatment of immune thrombocytopenia patients with moderate thrombocytopenia.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicoba | 2015 |
Efficacy of Helicobacter pylori eradication for the 1st line treatment of immune thrombocytopenia patients with moderate thrombocytopenia.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicoba | 2015 |
Efficacy of Helicobacter pylori eradication for the 1st line treatment of immune thrombocytopenia patients with moderate thrombocytopenia.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicoba | 2015 |
Long-term efficacy of Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura: 7-year follow-up prospective study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adrenal Cortex Hormones; Adult; Aged; Amoxicillin; Clarithr | 2009 |
Effect of Helicobacter pylori eradication on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Infective Agents; Chronic Disease; | 2004 |
Randomized study of Helicobacter pylori eradication therapy and proton pump inhibitor monotherapy for idiopathic thrombocytopenic purpura.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents | 2005 |
11 other studies available for lansoprazole and Autoimmune Thrombocytopenia
| Article | Year |
|---|---|
Iron deficiency anemia successfully treated by Helicobacter pylori eradication in a patient with idiopathic thrombocytopenic purpura.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anemia, Iron-Deficiency; Clarithromycin; Drug | 2009 |
Long term changes in platelet counts after H. pylori eradication in non-ITP patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer | 2010 |
Development of corpus atrophic gastritis may be associated with Helicobacter pylori-related idiopathic thrombocytopenic purpura.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithrom | 2011 |
Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial | 2002 |
[Helicobacter pylori eradication based upon a drug sensitivity test effectively increased platelet count in a patient with refractory idiopathic thrombocytopenic purpura].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Helicobacter Infections; Helicobacte | 2003 |
Secondary eradication of Helicobacter pylori was effective against refractory idiopathic thrombocytopenic purpura.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Blood Platelets; Drug Therapy, Combi | 2003 |
Effect of lansoprazole for an idiopathic thrombocytopenic purpura patient with Helicobacter pylori infection who did not respond to prednisolone treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Infective Agents; Helicobacter Infections; Helic | 2004 |
The Efficacy of Helicobacter pylori eradication in the treatment of idiopathic thrombocytopenic purpura--the first study in Turkey.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Clarithromycin | 2006 |
Helicobacter pylori eradication reduces platelet count in patients without idiopathic thrombocytopenic purpura.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clar | 2007 |
Refractory idiopathic thrombocytopenic purpura treated with the soluble tumor necrosis factor receptor etanercept.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Colchicine; Combined Modality | 2008 |
[Successful treatment of refractory idiopathic thrombocytopenic purpura by eradication of Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Th | 2001 |